Sign in
4

Changes in Ownership

Seres Therapeutics, Inc. Filed Acc 0000950170-25-017912

Options or other derivatives

  • CEO and President acquired 1,950,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Shaff Eric D. · CEO and President

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-02-07 Grant or award : show line 1 in the form Stock Option (Right to Buy) +1,950,000 1,950,000 D
Loading xslF345X05/ownership.xml…